LOPIN

This brand name is authorized in Nigeria. It is also authorized in Croatia.

Active ingredients

The drug LOPIN contains one active pharmaceutical ingredient (API):

1
UNII 864V2Q084H - AMLODIPINE BESYLATE
 

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.

 
Read more about Amlodipine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-0994 Tablet LOPIN-10 TABLET TAB 10 mg 10 X 10 104 RNW-PP-320116 LOPIN-10 TABLET AMLODIPINE BESYLATE USP 10MG AMLODIPINE BESYLATE USP 10MG, STARCH, LACTOSE, POVIDONE K 30, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, PURIFIED TALC, SODIUM STARCH GLYCOLATE A4-0994 Drugs Imported Products 10X10 POM 2 3/16/2023 GREENLIFE PHARMACEUTICALS LIMITED, 35A, ASSOCIATION AVENUE, ILUPEJU, LAGOS 17378995 greenlife.regulatory@yahoo.com SWISS PHARMA PVT LTD., 3709, G.I.D.C., PHASE-IV, VATVA, AHMEDABAD-382445, GUJARAT, INDIA, India 06/07/2023
A4-0995 Tablet LOPIN-5 TABLET TAB 5 mg 10 X 10 105 RNW-PP-320041 LOPIN-5 TABLET AMLODIPINE BESYLATE USP 5MG AMLODIPINE BESYLATE USP 5MG, STARCH, LACTOSE, POVIDONE K 30, ISOPROPYL ALCOHOL, MAGNESIUM STEARATE, PURIFIED TALC, SODIUM STARCH GLYCOLATE A4-0995 Drugs Imported Products 10X10 POM 1 3/16/2023 GREENLIFE PHARMACEUTICALS LIMITED, 35A, ASSOCIATION AVENUE, ILUPEJU, LAGOS 17378995 greenlife.regulatory@yahoo.com SWISS PHARMA PVT LTD., 3709, G.I.D.C., PHASE-IV, VATVA, AHMEDABAD-382445, GUJARAT, INDIA, India 06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C08CA01 Amlodipine C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
HR Agencija za lijekove i medicinske proizvode HR-H-053759540, HR-H-418532393
NG Registered Drug Product Database A4-0994, A4-0995

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.